What Is the Reckitt Benckiser Group PLC (RBGLY) Class Action Lawsuit About?

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Reckitt Benckiser Group PLC (“Reckitt” or “the Company”) (OTCMKTS: RBGLY) and certain of its officers.

Class Definition

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Reckitt securities between January 13, 2021, and July 28, 2024, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case.

What Does the Reckitt Benckiser Group PLC Securities Class Action Allege?

The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) that preterm infants were at an increased risk of developing necrotizing enterocolitis (“NEC”) by consuming Reckitt’s cow’s milk-based formula, Enfamil; (2) of the attendant impact on Reckitt’s sales of Enfamil and Reckitt’s exposure to legal claims; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

What’s Next?

A class action lawsuit has already been filed. You may review a copy of the Complaint. You may also contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660. If you suffered a loss in Reckitt you have until August 4, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff.